You are here

LAMA

Sunovion slammed by FDA rejection of nebulized LAMA for COPD as rival lines up a competing NDA

Endpoints

Tue, 05/30/17 - 11:21 am

Mylan acquires rights to novel LAMA respiratory compound from Pfizer

The Fly on the Wall

Wed, 12/18/13 - 09:52 am